Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
Go back to Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.05 | 52 Week High | $19.62 | |||
| Open | $2.05 | 52 Week Low | $7.65 | |||
| Day High | $2.05 | P/E | N/A | |||
| Day Low | $2.05 | EPS | $-0.22 | |||
| Volume | 11 | |||||
